行业指数
← 研究资料库

AO RESEARCH · 2026.10.03

行业研究与来源档案

按主题阅读统计、财务、赛事、参与调查、公共采购及场馆服务资料;原文时点、单位、地区与仍需对照确认的范围逐条保留。

资料条数不代表新产品、新法人或正式指数样本。来源中的发布、计分和图片使用批准状态保持原样。

研究简报与总报告

阅读行业指数研究总报告 →

条件化规格研究:逐一选择身份

7个异构研究身份、70条来源观察;分别展示,不计新增产品或70个统一标量参数。

三家公开装备发行人样本

100 条资料 · 1 / 5

来源版本与完整性

SHA-256 fe4e47549917b5cb1d345e31653743d2adc0d4134c5ff1e1828c8097d6f65cb5

保留原始来源版本,供研究复核。

来源记录 1
issuer legal name
舒华体育股份有限公司
entity scope
consolidated legal issuer group
期间开始
2024-01-01
期间结束
2024-12-31
期间类型
fiscal_year
年份
2024
指标
revenue_total
原指标名称
营业收入
原报告数词
1,417,094,638.60
原报告单位
元(人民币)
normalization factor
1
换算展示值
1417094638.60
换算单位
CNY
display value source units
1417094638.60
统计范围
consolidated issuer
dimension
— 未披露
资料状态
canonical
缺失原因
— 未披露
PDF页码
6
印刷页码
6
access utc
2026-10-03T11:10:45.592311+00:00
access window utc
— 未披露
evidence capture
captures/shuhua_2024_revised_p006.png
additional evidence
  • PDF页码
    6
    印刷页码
    6
    role
    superseded original table amount agreement for curated scope only
restatement scope
2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
continuing operations scope
Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
notes
— 未披露
是否符合正式公开使用条件
否
是否符合正式计分条件
否
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— 未披露
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 2
issuer legal name
舒华体育股份有限公司
entity scope
consolidated legal issuer group
期间开始
2024-01-01
期间结束
2024-12-31
期间类型
fiscal_year
年份
2024
指标
rd_expense
原指标名称
研发费用
原报告数词
43,673,742.07
原报告单位
元(人民币)
normalization factor
1
换算展示值
43673742.07
换算单位
CNY
display value source units
43673742.07
统计范围
consolidated issuer
dimension
— 未披露
资料状态
canonical
缺失原因
— 未披露
PDF页码
24
印刷页码
24
access utc
2026-10-03T11:10:45.592311+00:00
access window utc
— 未披露
evidence capture
captures/shuhua_2024_revised_p024.png
additional evidence
  • PDF页码
    24
    印刷页码
    24
    role
    superseded original table amount agreement for curated scope only
restatement scope
2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
continuing operations scope
Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
notes
Income statement expense; independently distinguished from total R&D input even where amounts match
是否符合正式公开使用条件
否
是否符合正式计分条件
否
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— 未披露
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 3
issuer legal name
舒华体育股份有限公司
entity scope
consolidated legal issuer group
期间开始
2024-01-01
期间结束
2024-12-31
期间类型
fiscal_year
年份
2024
指标
rd_input_total
原指标名称
研发投入合计
原报告数词
43,673,742.07
原报告单位
元(人民币)
normalization factor
1
换算展示值
43673742.07
换算单位
CNY
display value source units
43673742.07
统计范围
consolidated issuer
dimension
— 未披露
资料状态
canonical
缺失原因
— 未披露
PDF页码
24
印刷页码
24
access utc
2026-10-03T11:10:45.592311+00:00
access window utc
— 未披露
evidence capture
captures/shuhua_2024_revised_p024.png
additional evidence
  • PDF页码
    24
    印刷页码
    24
    role
    superseded original table amount agreement for curated scope only
restatement scope
2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
continuing operations scope
Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
notes
Total R&D input as disclosed, not substituted from expense
是否符合正式公开使用条件
否
是否符合正式计分条件
否
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— 未披露
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 4
issuer legal name
舒华体育股份有限公司
entity scope
consolidated legal issuer group
期间开始
2024-01-01
期间结束
2024-12-31
期间类型
fiscal_year
年份
2024
指标
rd_input_capitalized
原指标名称
本期资本化研发投入
原报告数词
0.00
原报告单位
元(人民币)
normalization factor
1
换算展示值
0.00
换算单位
CNY
display value source units
0.00
统计范围
consolidated issuer
dimension
— 未披露
资料状态
canonical
缺失原因
— 未披露
PDF页码
24
印刷页码
24
access utc
2026-10-03T11:10:45.592311+00:00
access window utc
— 未披露
evidence capture
captures/shuhua_2024_revised_p024.png
additional evidence
  • PDF页码
    24
    印刷页码
    24
    role
    superseded original table amount agreement for curated scope only
restatement scope
2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
continuing operations scope
Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
notes
— 未披露
是否符合正式公开使用条件
否
是否符合正式计分条件
否
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— 未披露
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 5
issuer legal name
舒华体育股份有限公司
entity scope
consolidated legal issuer group
期间开始
2024-01-01
期间结束
2024-12-31
期间类型
fiscal_year
年份
2024
指标
rd_intensity_reported
原指标名称
研发投入总额占营业收入比例(%)
原报告数词
3.08
原报告单位
%
normalization factor
0.01
换算展示值
0.0308
换算单位
ratio
display value source units
3.08
统计范围
consolidated issuer
dimension
— 未披露
资料状态
canonical
缺失原因
— 未披露
PDF页码
24
印刷页码
24
access utc
2026-10-03T11:10:45.592311+00:00
access window utc
— 未披露
evidence capture
captures/shuhua_2024_revised_p024.png
additional evidence
  • PDF页码
    24
    印刷页码
    24
    role
    superseded original table amount agreement for curated scope only
restatement scope
2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
continuing operations scope
Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
notes
Issuer rounded percentage; derived ratio stored separately
是否符合正式公开使用条件
否
是否符合正式计分条件
否
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— 未披露
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 6
issuer legal name
舒华体育股份有限公司
entity scope
consolidated legal issuer group
期间开始
2025-01-01
期间结束
2025-12-31
期间类型
fiscal_year
年份
2025
指标
revenue_total
原指标名称
营业收入
原报告数词
1,566,259,241.04
原报告单位
元(人民币)
normalization factor
1
换算展示值
1566259241.04
换算单位
CNY
display value source units
1566259241.04
统计范围
consolidated issuer
dimension
— 未披露
资料状态
canonical
缺失原因
— 未披露
PDF页码
7
印刷页码
7
access utc
2026-10-03T11:08:10.246189+00:00
access window utc
— 未披露
evidence capture
captures/shuhua_2025_p007.png
additional evidence
— 未披露
restatement scope
2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
continuing operations scope
Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
notes
— 未披露
是否符合正式公开使用条件
否
是否符合正式计分条件
否
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— 未披露
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 7
issuer legal name
舒华体育股份有限公司
entity scope
consolidated legal issuer group
期间开始
2025-01-01
期间结束
2025-12-31
期间类型
fiscal_year
年份
2025
指标
rd_expense
原指标名称
研发费用
原报告数词
53,588,214.84
原报告单位
元(人民币)
normalization factor
1
换算展示值
53588214.84
换算单位
CNY
display value source units
53588214.84
统计范围
consolidated issuer
dimension
— 未披露
资料状态
canonical
缺失原因
— 未披露
PDF页码
25
印刷页码
25
access utc
2026-10-03T11:08:10.246189+00:00
access window utc
— 未披露
evidence capture
captures/shuhua_2025_p025.png
additional evidence
— 未披露
restatement scope
2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
continuing operations scope
Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
notes
Income statement expense; independently distinguished from total R&D input even where amounts match
是否符合正式公开使用条件
否
是否符合正式计分条件
否
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— 未披露
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 8
issuer legal name
舒华体育股份有限公司
entity scope
consolidated legal issuer group
期间开始
2025-01-01
期间结束
2025-12-31
期间类型
fiscal_year
年份
2025
指标
rd_input_total
原指标名称
研发投入合计
原报告数词
53,588,214.84
原报告单位
元(人民币)
normalization factor
1
换算展示值
53588214.84
换算单位
CNY
display value source units
53588214.84
统计范围
consolidated issuer
dimension
— 未披露
资料状态
canonical
缺失原因
— 未披露
PDF页码
26
印刷页码
26
access utc
2026-10-03T11:08:10.246189+00:00
access window utc
— 未披露
evidence capture
captures/shuhua_2025_p026.png
additional evidence
— 未披露
restatement scope
2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
continuing operations scope
Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
notes
Total R&D input as disclosed, not substituted from expense
是否符合正式公开使用条件
否
是否符合正式计分条件
否
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— 未披露
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 9
issuer legal name
舒华体育股份有限公司
entity scope
consolidated legal issuer group
期间开始
2025-01-01
期间结束
2025-12-31
期间类型
fiscal_year
年份
2025
指标
rd_input_capitalized
原指标名称
本期资本化研发投入
原报告数词
0.00
原报告单位
元(人民币)
normalization factor
1
换算展示值
0.00
换算单位
CNY
display value source units
0.00
统计范围
consolidated issuer
dimension
— 未披露
资料状态
canonical
缺失原因
— 未披露
PDF页码
26
印刷页码
26
access utc
2026-10-03T11:08:10.246189+00:00
access window utc
— 未披露
evidence capture
captures/shuhua_2025_p026.png
additional evidence
— 未披露
restatement scope
2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
continuing operations scope
Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
notes
— 未披露
是否符合正式公开使用条件
否
是否符合正式计分条件
否
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— 未披露
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 10
issuer legal name
舒华体育股份有限公司
entity scope
consolidated legal issuer group
期间开始
2025-01-01
期间结束
2025-12-31
期间类型
fiscal_year
年份
2025
指标
rd_intensity_reported
原指标名称
研发投入总额占营业收入比例(%)
原报告数词
3.42
原报告单位
%
normalization factor
0.01
换算展示值
0.0342
换算单位
ratio
display value source units
3.42
统计范围
consolidated issuer
dimension
— 未披露
资料状态
canonical
缺失原因
— 未披露
PDF页码
26
印刷页码
26
access utc
2026-10-03T11:08:10.246189+00:00
access window utc
— 未披露
evidence capture
captures/shuhua_2025_p026.png
additional evidence
— 未披露
restatement scope
2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
continuing operations scope
Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
notes
Issuer rounded percentage; derived ratio stored separately
是否符合正式公开使用条件
否
是否符合正式计分条件
否
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— 未披露
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 11
issuer legal name
青岛英派斯健康科技股份有限公司
entity scope
consolidated legal issuer group
期间开始
2024-01-01
期间结束
2024-12-31
期间类型
fiscal_year
年份
2024
指标
revenue_total
原指标名称
营业收入
原报告数词
1,213,857,643.97
原报告单位
元(人民币)
normalization factor
1
换算展示值
1213857643.97
换算单位
CNY
display value source units
1213857643.97
统计范围
consolidated issuer
dimension
— 未披露
资料状态
canonical
缺失原因
— 未披露
PDF页码
8
印刷页码
8
access utc
2026-10-03T11:09:47.328225+00:00
access window utc
— 未披露
evidence capture
captures/impulse_2024_p008.png
additional evidence
— 未披露
restatement scope
No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
continuing operations scope
Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
notes
— 未披露
是否符合正式公开使用条件
否
是否符合正式计分条件
否
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— 未披露
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 12
issuer legal name
青岛英派斯健康科技股份有限公司
entity scope
consolidated legal issuer group
期间开始
2024-01-01
期间结束
2024-12-31
期间类型
fiscal_year
年份
2024
指标
rd_expense
原指标名称
研发费用
原报告数词
52,552,467.25
原报告单位
元(人民币)
normalization factor
1
换算展示值
52552467.25
换算单位
CNY
display value source units
52552467.25
统计范围
consolidated issuer
dimension
— 未披露
资料状态
canonical
缺失原因
— 未披露
PDF页码
30
印刷页码
30
access utc
2026-10-03T11:09:47.328225+00:00
access window utc
— 未披露
evidence capture
captures/impulse_2024_p030.png
additional evidence
— 未披露
restatement scope
No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
continuing operations scope
Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
notes
Income statement expense; independently distinguished from total R&D input even where amounts match
是否符合正式公开使用条件
否
是否符合正式计分条件
否
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— 未披露
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 13
issuer legal name
青岛英派斯健康科技股份有限公司
entity scope
consolidated legal issuer group
期间开始
2024-01-01
期间结束
2024-12-31
期间类型
fiscal_year
年份
2024
指标
rd_input_total
原指标名称
研发投入金额(元)
原报告数词
52,552,467.25
原报告单位
元(人民币)
normalization factor
1
换算展示值
52552467.25
换算单位
CNY
display value source units
52552467.25
统计范围
consolidated issuer
dimension
— 未披露
资料状态
canonical
缺失原因
— 未披露
PDF页码
32
印刷页码
32
access utc
2026-10-03T11:09:47.328225+00:00
access window utc
— 未披露
evidence capture
captures/impulse_2024_p032.png
additional evidence
— 未披露
restatement scope
No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
continuing operations scope
Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
notes
Total R&D input as disclosed, not substituted from expense
是否符合正式公开使用条件
否
是否符合正式计分条件
否
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— 未披露
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 14
issuer legal name
青岛英派斯健康科技股份有限公司
entity scope
consolidated legal issuer group
期间开始
2024-01-01
期间结束
2024-12-31
期间类型
fiscal_year
年份
2024
指标
rd_input_capitalized
原指标名称
研发投入资本化的金额(元)
原报告数词
0.00
原报告单位
元(人民币)
normalization factor
1
换算展示值
0.00
换算单位
CNY
display value source units
0.00
统计范围
consolidated issuer
dimension
— 未披露
资料状态
canonical
缺失原因
— 未披露
PDF页码
32
印刷页码
32
access utc
2026-10-03T11:09:47.328225+00:00
access window utc
— 未披露
evidence capture
captures/impulse_2024_p032.png
additional evidence
— 未披露
restatement scope
No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
continuing operations scope
Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
notes
— 未披露
是否符合正式公开使用条件
否
是否符合正式计分条件
否
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— 未披露
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 15
issuer legal name
青岛英派斯健康科技股份有限公司
entity scope
consolidated legal issuer group
期间开始
2024-01-01
期间结束
2024-12-31
期间类型
fiscal_year
年份
2024
指标
rd_intensity_reported
原指标名称
研发投入占营业收入比例
原报告数词
4.33%
原报告单位
%
normalization factor
0.01
换算展示值
0.0433
换算单位
ratio
display value source units
4.33
统计范围
consolidated issuer
dimension
— 未披露
资料状态
canonical
缺失原因
— 未披露
PDF页码
32
印刷页码
32
access utc
2026-10-03T11:09:47.328225+00:00
access window utc
— 未披露
evidence capture
captures/impulse_2024_p032.png
additional evidence
— 未披露
restatement scope
No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
continuing operations scope
Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
notes
Issuer rounded percentage; derived ratio stored separately
是否符合正式公开使用条件
否
是否符合正式计分条件
否
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— 未披露
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 16
issuer legal name
青岛英派斯健康科技股份有限公司
entity scope
consolidated legal issuer group
期间开始
2025-01-01
期间结束
2025-12-31
期间类型
fiscal_year
年份
2025
指标
revenue_total
原指标名称
营业收入
原报告数词
1,175,906,664.10
原报告单位
元(人民币)
normalization factor
1
换算展示值
1175906664.10
换算单位
CNY
display value source units
1175906664.10
统计范围
consolidated issuer
dimension
— 未披露
资料状态
canonical
缺失原因
— 未披露
PDF页码
8
印刷页码
8
access utc
— 未披露
access window utc
  • 2026-10-03T11:00:30Z
  • 2026-10-03T11:03:00Z
evidence capture
captures/impulse_2025_p008.png
additional evidence
— 未披露
restatement scope
No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
continuing operations scope
Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
notes
— 未披露
是否符合正式公开使用条件
否
是否符合正式计分条件
否
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— 未披露
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 17
issuer legal name
青岛英派斯健康科技股份有限公司
entity scope
consolidated legal issuer group
期间开始
2025-01-01
期间结束
2025-12-31
期间类型
fiscal_year
年份
2025
指标
rd_expense
原指标名称
研发费用
原报告数词
51,565,452.91
原报告单位
元(人民币)
normalization factor
1
换算展示值
51565452.91
换算单位
CNY
display value source units
51565452.91
统计范围
consolidated issuer
dimension
— 未披露
资料状态
canonical
缺失原因
— 未披露
PDF页码
28
印刷页码
28
access utc
— 未披露
access window utc
  • 2026-10-03T11:00:30Z
  • 2026-10-03T11:03:00Z
evidence capture
captures/impulse_2025_p028.png
additional evidence
— 未披露
restatement scope
No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
continuing operations scope
Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
notes
Income statement expense; independently distinguished from total R&D input even where amounts match
是否符合正式公开使用条件
否
是否符合正式计分条件
否
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— 未披露
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 18
issuer legal name
青岛英派斯健康科技股份有限公司
entity scope
consolidated legal issuer group
期间开始
2025-01-01
期间结束
2025-12-31
期间类型
fiscal_year
年份
2025
指标
rd_input_total
原指标名称
研发投入金额(元)
原报告数词
51,565,452.91
原报告单位
元(人民币)
normalization factor
1
换算展示值
51565452.91
换算单位
CNY
display value source units
51565452.91
统计范围
consolidated issuer
dimension
— 未披露
资料状态
canonical
缺失原因
— 未披露
PDF页码
29
印刷页码
29
access utc
— 未披露
access window utc
  • 2026-10-03T11:00:30Z
  • 2026-10-03T11:03:00Z
evidence capture
captures/impulse_2025_p029.png
additional evidence
— 未披露
restatement scope
No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
continuing operations scope
Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
notes
Total R&D input as disclosed, not substituted from expense
是否符合正式公开使用条件
否
是否符合正式计分条件
否
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— 未披露
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 19
issuer legal name
青岛英派斯健康科技股份有限公司
entity scope
consolidated legal issuer group
期间开始
2025-01-01
期间结束
2025-12-31
期间类型
fiscal_year
年份
2025
指标
rd_input_capitalized
原指标名称
研发投入资本化的金额(元)
原报告数词
0.00
原报告单位
元(人民币)
normalization factor
1
换算展示值
0.00
换算单位
CNY
display value source units
0.00
统计范围
consolidated issuer
dimension
— 未披露
资料状态
canonical
缺失原因
— 未披露
PDF页码
29
印刷页码
29
access utc
— 未披露
access window utc
  • 2026-10-03T11:00:30Z
  • 2026-10-03T11:03:00Z
evidence capture
captures/impulse_2025_p029.png
additional evidence
— 未披露
restatement scope
No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
continuing operations scope
Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
notes
— 未披露
是否符合正式公开使用条件
否
是否符合正式计分条件
否
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— 未披露
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
来源记录 20
issuer legal name
青岛英派斯健康科技股份有限公司
entity scope
consolidated legal issuer group
期间开始
2025-01-01
期间结束
2025-12-31
期间类型
fiscal_year
年份
2025
指标
rd_intensity_reported
原指标名称
研发投入占营业收入比例
原报告数词
4.39%
原报告单位
%
normalization factor
0.01
换算展示值
0.0439
换算单位
ratio
display value source units
4.39
统计范围
consolidated issuer
dimension
— 未披露
资料状态
canonical
缺失原因
— 未披露
PDF页码
29
印刷页码
29
access utc
— 未披露
access window utc
  • 2026-10-03T11:00:30Z
  • 2026-10-03T11:03:00Z
evidence capture
captures/impulse_2025_p029.png
additional evidence
— 未披露
restatement scope
No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
continuing operations scope
Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
notes
Issuer rounded percentage; derived ratio stored separately
是否符合正式公开使用条件
否
是否符合正式计分条件
否
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— 未披露
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.